# active_site_0065

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **C** — Position 143 (Proton acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MADKETLLKLREDFKMQNKSVFILGASGETGKVLLKEILGQNLFSKVTLIGRRKLTFEEEAYNNVNQEVVDFEKLDEYAPAFQGHDVGFCCLGTTRRKAGADGFVRVDRDYVLKSAELAKAGGCKHFNLLSSRGADKSSSFLYLQVKGEVEAKVEELKFDRLSVFRPGVLLCDRQESRPGEWLARKFFGSLPDSWASGYAVPVVTVVRAMLNNLVSPGSGQMELLENKAILHLGKDSDGPKL

[Multiple Choices]
A. Position 1978 (For beta-ketoacyl synthase 2 activity)
B. Position 436 (Proton acceptor)
C. Position 143 (Proton acceptor)
D. Position 12 (Proton acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact 242-residue sequence matches the UniProt record, which annotates residue 143 as the proton acceptor. The annotation is transferred by similarity from Q9BUP3 (ECO:0000250), not direct experimental evidence for this rat protein in the supplied evidence.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence and choices provide no defensible way to identify residue 143 specifically as the proton acceptor; generic residue chemistry or sequence patterns cannot establish that site assignment.


**Missing item-specific fact**

> The protein-specific annotation assigning proton-acceptor activity to residue 143, or equivalent experimental evidence.


**Reason**

> Although the key is supported by a sequence-matched database annotation, that annotation was not supplied to the evaluated model. Choosing the exact numbered catalytic residue therefore depends on an external protein-specific fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed options, only position 143 is annotated as the proton acceptor in the sequence-matched record. The reviewer evidence does not establish the other choices as equivalent proton-acceptor sites.


### Important caveats

- The residue-143 annotation is evidence by similarity to Q9BUP3, not demonstrated here by direct experiments on this rat protein.
- The exact author source snapshot is unknown, though the sequence matches both the current record and the cited historical record.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence and choices provide no defensible way to identify residue 143 specifically as the proton acceptor; generic residue chemistry or sequence patterns cannot establish that site assignment.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation assigning proton-acceptor activity to residue 143, or equivalent experimental evidence.",
    "reason": "Although the key is supported by a sequence-matched database annotation, that annotation was not supplied to the evaluated model. Choosing the exact numbered catalytic residue therefore depends on an external protein-specific fact."
  },
  "case_id": "active_site_0065",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact 242-residue sequence matches the UniProt record, which annotates residue 143 as the proton acceptor. The annotation is transferred by similarity from Q9BUP3 (ECO:0000250), not direct experimental evidence for this rat protein in the supplied evidence."
  },
  "important_caveats": [
    "The residue-143 annotation is evidence by similarity to Q9BUP3, not demonstrated here by direct experiments on this rat protein.",
    "The exact author source snapshot is unknown, though the sequence matches both the current record and the cited historical record."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, only position 143 is annotated as the proton acceptor in the sequence-matched record. The reviewer evidence does not establish the other choices as equivalent proton-acceptor sites."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0065",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact 242-residue sequence matches the UniProt record, which annotates residue 143 as the proton acceptor. The annotation is transferred by similarity from Q9BUP3 (ECO:0000250), not direct experimental evidence for this rat protein in the supplied evidence.",
    "evidence_ids": ["C1", "C5", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence and choices provide no defensible way to identify residue 143 specifically as the proton acceptor; generic residue chemistry or sequence patterns cannot establish that site assignment.",
    "missing_item_specific_fact": "The protein-specific annotation assigning proton-acceptor activity to residue 143, or equivalent experimental evidence.",
    "reason": "Although the key is supported by a sequence-matched database annotation, that annotation was not supplied to the evaluated model. Choosing the exact numbered catalytic residue therefore depends on an external protein-specific fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, only position 143 is annotated as the proton acceptor in the sequence-matched record. The reviewer evidence does not establish the other choices as equivalent proton-acceptor sites."
  },
  "important_caveats": [
    "The residue-143 annotation is evidence by similarity to Q9BUP3, not demonstrated here by direct experiments on this rat protein.",
    "The exact author source snapshot is unknown, though the sequence matches both the current record and the cited historical record."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry B0BNF8 (Rat HTATIP2, 242 AA, sequence matched) annotates position 143 as 'Active site: Proton acceptor' (evidence C5/H2). The evidence code is ECO:0000250 (similarity to Q9BUP3, human ortholog), meaning the annotation is transferred by homology rather than direct experimental determination on this rat protein. Nevertheless, the database annotation does support the author's key. The protein sequence confirms position 143 is Tyrosine (Y), consistent with a proton-acceptor role.

Citations as saved: [C5](#evidence-c5), [H2](#evidence-h2), [C1](#evidence-c1), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Options A (position 1978) and B (position 436) are trivially eliminable because the protein is only 242 residues long. However, between C (position 143, Tyr) and D (position 12, Glu), no general biological reasoning from the 242-residue sequence alone can identify position 143 as the proton acceptor. The 'active site' annotation is transferred by similarity (ECO:0000250) from the human ortholog Q9BUP3, not derived from experimental catalytic characterization. HTATIP2 is not a classical enzyme with a well-known catalytic mechanism inferable from sequence motifs.


**Missing item-specific fact**

> The specific UniProt annotation transferring a 'Proton acceptor' active-site role to position 143 via homology to Q9BUP3, and the NADPH-binding-site context (positions 143, 147 also annotated as NADPH binding) that situates the catalytic residue within a cofactor-binding region. Without this item-specific database annotation, the sequence provides no obvious catalytic motif or structural context to prefer Tyr-143 over Glu-12 as a proton acceptor.


**Reason**

> Eliminating A and B by protein length is trivial arithmetic, not biological reasoning. Distinguishing C from D requires knowledge of the specific protein's annotated catalytic role, which is a database lookup (transferred annotation) rather than a deduction from general enzyme chemistry or sequence patterns visible in the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Once A and B are eliminated as out-of-range, only C and D remain within the 242-residue sequence. The UniProt annotation uniquely designates position 143 as the proton acceptor; position 12 has no active-site annotation. No ambiguity in the correct answer per the database, though the annotation itself is by similarity rather than direct experiment.


### Important caveats

- The active-site annotation at position 143 carries evidence code ECO:0000250 (similarity to Q9BUP3), meaning it is a transferred annotation, not an experimentally validated catalytic residue for this rat protein.
- HTATIP2 (TIP30/CC2D1A) is primarily described as a protein interacting with HIV Tat, not a classical enzyme; the 'active site' and 'proton acceptor' labels derive from homology-based annotation and should be interpreted cautiously.
- The protein identity (HTATIP2) and the specific annotation were not provided to the evaluated model; only the raw 242-residue sequence was given.
- Options A and B are trivially eliminable by protein length, reducing effective discrimination to a two-way choice (C vs D) that still depends on item-specific annotation knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Options A (position 1978) and B (position 436) are trivially eliminable because the protein is only 242 residues long. However, between C (position 143, Tyr) and D (position 12, Glu), no general biological reasoning from the 242-residue sequence alone can identify position 143 as the proton acceptor. The 'active site' annotation is transferred by similarity (ECO:0000250) from the human ortholog Q9BUP3, not derived from experimental catalytic characterization. HTATIP2 is not a classical enzyme with a well-known catalytic mechanism inferable from sequence motifs.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific UniProt annotation transferring a 'Proton acceptor' active-site role to position 143 via homology to Q9BUP3, and the NADPH-binding-site context (positions 143, 147 also annotated as NADPH binding) that situates the catalytic residue within a cofactor-binding region. Without this item-specific database annotation, the sequence provides no obvious catalytic motif or structural context to prefer Tyr-143 over Glu-12 as a proton acceptor.",
    "reason": "Eliminating A and B by protein length is trivial arithmetic, not biological reasoning. Distinguishing C from D requires knowledge of the specific protein's annotated catalytic role, which is a database lookup (transferred annotation) rather than a deduction from general enzyme chemistry or sequence patterns visible in the input."
  },
  "case_id": "active_site_0065",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H2",
      "C1",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry B0BNF8 (Rat HTATIP2, 242 AA, sequence matched) annotates position 143 as 'Active site: Proton acceptor' (evidence C5/H2). The evidence code is ECO:0000250 (similarity to Q9BUP3, human ortholog), meaning the annotation is transferred by homology rather than direct experimental determination on this rat protein. Nevertheless, the database annotation does support the author's key. The protein sequence confirms position 143 is Tyrosine (Y), consistent with a proton-acceptor role."
  },
  "important_caveats": [
    "The active-site annotation at position 143 carries evidence code ECO:0000250 (similarity to Q9BUP3), meaning it is a transferred annotation, not an experimentally validated catalytic residue for this rat protein.",
    "HTATIP2 (TIP30/CC2D1A) is primarily described as a protein interacting with HIV Tat, not a classical enzyme; the 'active site' and 'proton acceptor' labels derive from homology-based annotation and should be interpreted cautiously.",
    "The protein identity (HTATIP2) and the specific annotation were not provided to the evaluated model; only the raw 242-residue sequence was given.",
    "Options A and B are trivially eliminable by protein length, reducing effective discrimination to a two-way choice (C vs D) that still depends on item-specific annotation knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Once A and B are eliminated as out-of-range, only C and D remain within the 242-residue sequence. The UniProt annotation uniquely designates position 143 as the proton acceptor; position 12 has no active-site annotation. No ambiguity in the correct answer per the database, though the annotation itself is by similarity rather than direct experiment."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0065",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry B0BNF8 (Rat HTATIP2, 242 AA, sequence matched) annotates position 143 as 'Active site: Proton acceptor' (evidence C5/H2). The evidence code is ECO:0000250 (similarity to Q9BUP3, human ortholog), meaning the annotation is transferred by homology rather than direct experimental determination on this rat protein. Nevertheless, the database annotation does support the author's key. The protein sequence confirms position 143 is Tyrosine (Y), consistent with a proton-acceptor role.",
    "evidence_ids": ["C5", "H2", "C1", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Options A (position 1978) and B (position 436) are trivially eliminable because the protein is only 242 residues long. However, between C (position 143, Tyr) and D (position 12, Glu), no general biological reasoning from the 242-residue sequence alone can identify position 143 as the proton acceptor. The 'active site' annotation is transferred by similarity (ECO:0000250) from the human ortholog Q9BUP3, not derived from experimental catalytic characterization. HTATIP2 is not a classical enzyme with a well-known catalytic mechanism inferable from sequence motifs.",
    "missing_item_specific_fact": "The specific UniProt annotation transferring a 'Proton acceptor' active-site role to position 143 via homology to Q9BUP3, and the NADPH-binding-site context (positions 143, 147 also annotated as NADPH binding) that situates the catalytic residue within a cofactor-binding region. Without this item-specific database annotation, the sequence provides no obvious catalytic motif or structural context to prefer Tyr-143 over Glu-12 as a proton acceptor.",
    "reason": "Eliminating A and B by protein length is trivial arithmetic, not biological reasoning. Distinguishing C from D requires knowledge of the specific protein's annotated catalytic role, which is a database lookup (transferred annotation) rather than a deduction from general enzyme chemistry or sequence patterns visible in the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Once A and B are eliminated as out-of-range, only C and D remain within the 242-residue sequence. The UniProt annotation uniquely designates position 143 as the proton acceptor; position 12 has no active-site annotation. No ambiguity in the correct answer per the database, though the annotation itself is by similarity rather than direct experiment."
  },
  "important_caveats": [
    "The active-site annotation at position 143 carries evidence code ECO:0000250 (similarity to Q9BUP3), meaning it is a transferred annotation, not an experimentally validated catalytic residue for this rat protein.",
    "HTATIP2 (TIP30/CC2D1A) is primarily described as a protein interacting with HIV Tat, not a classical enzyme; the 'active site' and 'proton acceptor' labels derive from homology-based annotation and should be interpreted cautiously.",
    "The protein identity (HTATIP2) and the specific annotation were not provided to the evaluated model; only the raw 242-residue sequence was given.",
    "Options A and B are trivially eliminable by protein length, reducing effective discrimination to a two-way choice (C vs D) that still depends on item-specific annotation knowledge."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `B0BNF8` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 117. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B0BNF8.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:12.867856+00:00.  

```json
"B0BNF8"
```

Source SHA-256: `5bc2319a85294d9bd0de3c58ce0c0ccfe250318e8fba8d882b03e077196791bb`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B0BNF8.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:12.867856+00:00.  

```json
{"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Protein HTATIP2"}}}
```

Source SHA-256: `5bc2319a85294d9bd0de3c58ce0c0ccfe250318e8fba8d882b03e077196791bb`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B0BNF8.json)  
**Locator:** `/features/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:12.867856+00:00.  

```json
{"description":"Proton acceptor","evidences":[{"evidenceCode":"ECO:0000250","id":"Q9BUP3","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":143},"start":{"modifier":"EXACT","value":143}},"type":"Active site"}
```

Source SHA-256: `5bc2319a85294d9bd0de3c58ce0c0ccfe250318e8fba8d882b03e077196791bb`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B0BNF8?format=txt&versions=117)  
**Locator:** `lines 157-159`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 117 / 1.  
**Retrieved:** 2026-11-02T04:27:16.468432+00:00.  

```text
FT   ACT_SITE        143
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BUP3"
```

Source SHA-256: `c91b6ccd39bbf56d358216a7ae481826bd770d8f3f708b47271a14d3c7924ec0`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 65. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
